Allan–Herndon–Dudley syndrome (AHDS) caused by a novel SLC16A2 gene mutation showing severe neurologic features and unexpectedly low TRH-stimulated serum TSH
- 1 November 2010
- journal article
- case report
- Published by Elsevier BV in European Journal of Medical Genetics
- Vol. 53 (6), 392-395
- https://doi.org/10.1016/j.ejmg.2010.08.001
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Elevated serum triiodothyronine and intellectual and motor disability with paroxysmal dyskinesia caused by a monocarboxylate transporter 8 gene mutationDevelopmental Medicine and Child Neurology, 2009
- Novel pathogenic mechanism suggested by ex vivo analysis of MCT8 (SLC16A2) mutationsHuman Mutation, 2008
- An Evaluation of the Thyrotrophin-Releasing Hormone Stimulation Test in Paediatric Clinical PracticeHormone Research in Paediatrics, 2007
- Clinical phenotype and endocrinological investigations in a patient with a mutation in the MCT8 thyroid hormone transporterEuropean Journal of Pediatrics, 2007
- The MCT8 thyroid hormone transporter and Allan–Herndon–Dudley syndromeBest Practice & Research Clinical Endocrinology & Metabolism, 2007
- Novel Biological and Clinical Aspects of Thyroid Hormone MetabolismEndocrine development, 2007
- Unexpected Peripheral Markers of Thyroid Function in a Patient with a Novel Mutation of the MCT8 Thyroid Hormone Transporter GeneHormone Research in Paediatrics, 2006
- Mechanisms of Disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8Nature Clinical Practice Endocrinology & Metabolism, 2006
- Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporterJournal of Medical Genetics, 2005
- The combined pituitary function test in children: an evaluation of the clinical usefulness of TRH and LHRH stimulation tests through a retrospective analysis of one hundred and twenty six casesClinical Endocrinology, 2000